Categories: aggregated

The Billion Dollar Psilocybin Patent Race – Can One Company Actually Patent the Psilocybin Molecule?

The release of fresh information from a nonprofit dedicated to furthering our knowledge of psilocybin has provoked a dispute between corporations hoping to profit from new discoveries by obtaining patent protection and traditionalists who oppose psilocybin’s patenting.

Jason

Share
Published by
Jason

Recent Posts

In Germany’s Cannabis Clubs, You Smoke Alone

Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…

5 hours ago

The Real Wacky Tobacky: Scientists Rewire Tobacco Plant to Make Psychedelics

The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…

5 hours ago

‘Addiction Factory’: Study Denounces the Dangers of Overdiagnosing Habits

The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…

5 hours ago

Most Americans Want Marijuana Legalized. What They Got Was Schedule III

Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…

5 hours ago

Marijuana Reclassification Explained: What the Trump Administration’s Schedule 3 Move Actually Means

On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…

5 hours ago

420 Consciousness and the War Machine – When Opposites Collide

Here we are in 2026, and a conflict that was supposed to wrap up in…

5 hours ago